Lineage Cell Therapeutics Inc
XBER:BT3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lineage Cell Therapeutics Inc
XBER:BT3
|
US |
|
World Acceptance Corp
NASDAQ:WRLD
|
US |
|
C
|
Capitol Federal Financial Inc
F:CFW
|
US |
|
Sasol Ltd
F:SAOA
|
ZA |
|
M
|
M/I Homes Inc
F:4MI
|
US |
|
Freshworks Inc
F:7DF
|
US |
|
T
|
TMX Group Ltd
F:9TX
|
CA |
|
D
|
Denka Co Ltd
DUS:DIK
|
JP |
|
M
|
Mincon Group PLC
ISEQ:MIO
|
IE |
|
U
|
Unilever PLC
XBER:UNVB
|
UK |
|
Shinkin Central Bank
TSE:8421
|
JP |
|
E
|
Endeavour Silver Corp
F:EJD
|
CA |
|
P
|
Pensionbee Group PLC
F:6HD
|
UK |
|
Orient Overseas (International) Ltd
F:ORI
|
HK |
|
C
|
Canadian National Railway Co
XBER:CY2
|
CA |
|
P
|
Paccar Inc
DUS:PAE
|
US |
|
B
|
Ball Corp
F:BL8
|
US |
|
C
|
Cummins Inc
DUS:CUM
|
US |
|
Carter's Inc
NYSE:CRI
|
US |
|
Xcel Brands Inc
NASDAQ:XELB
|
US |
|
B
|
Bunge Ltd
XBER:BU3
|
US |
|
MFS Inc
TSE:196A
|
JP |
|
N
|
Nexon Co Ltd
XMUN:7NX
|
JP |
|
Harley-Davidson Inc
NYSE:HOG
|
US |
Bankruptcy Probability
Lineage Cell Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Lineage Cell Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
L
|
Lineage Cell Therapeutics Inc
TASE:LCTX
|
318.1m ILS |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
438.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
196.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
161.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
123.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
70.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Lineage Cell Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Lineage Cell Therapeutics Inc has total debt of 32k USD. This includes both short-term (0 USD) and long-term (32k USD) debt.
You can find a full breakdown on its Balance Sheet.
